ColumbiaMagazine.com
Printed from:

Welcome to Columbia Magazine  
 



































 
LWC Swimming hosts hour of power relay on Tuesday

By Christopher Coombs

The Lindsey Wilson men and women's swim teams will take to the Holloway Center Natatorium pool on Tuesday, joining thousands of fellow student-athletes across the nation to celebrate the 14th Annual Ted Mullin "Leave it in the Pool" Hour of Power Relay for Sarcoma Research, sponsored by the Carleton College swimming and diving teams.

The Hour of Power is set to begin at 4pmCT on Tuesday, Nov. 26 in the Holloway Health and Wellness Center Natatorium. You can make a donation online at www.tedmullinfund.org.

Joining the Blue Raiders at the Holloway Center Natatorium will be the Campbellsville University men and women's swim and dive team.

The objective of the "Leave it in the Pool" practice is to participate in continuous relays of any stroke for one-straight hour, with the objective of keeping all relays in each lane on the same length.



The Hour of Power event honors those who are fighting or have succumbed to cancer, including former Carleton swimmer Edward H. "Ted" Mullin, who passed away from synovial sarcoma, a rare soft-tissue cancer, in September 2006.

The funds go to support research at the University of Chicago Medicine Comer Children's Hospital into the causes and treatment of sarcoma and other rare pediatric cancers.

The initiative has been used for a variety of projects that evaluate the genetic basis of sarcomas, the identification of novel markers of disease diagnosis or progression, and the development of new small molecule and cell therapies for resistant disease. Money raised acts as seed funding for the University of Chicago Medicine's (UCM) pediatric cancer research program. The Ted Mullin Fund has supported research into novel chemotherapy/biology agents, new ways to administer chemotherapy, techniques to visualize more accurately the tumor response in the patient, novel genomics strategies to identify high-risk sarcoma patients, molecular techniques to personalize therapy to maximize benefit while reducing treatment-related toxicity, and treatments for metastatic or resistant disease that use the patient's own immune system to attack residual tumors.


This story was posted on 2019-11-26 12:28:48
Printable: this page is now automatically formatted for printing.
Have comments or corrections for this story? Use our contact form and let us know.



 

































 
 
Quick Links to Popular Features


Looking for a story or picture?
Try our Photo Archive or our Stories Archive for all the information that's appeared on ColumbiaMagazine.com.

 

Contact us: Columbia Magazine and columbiamagazine.com are published by Linda Waggener and Pen Waggener, PO Box 906, Columbia, KY 42728.
Phone: 270.403.0017


Please use our contact page, or send questions about technical issues with this site to webmaster@columbiamagazine.com. All logos and trademarks used on this site are property of their respective owners. All comments remain the property and responsibility of their posters, all articles and photos remain the property of their creators, and all the rest is copyright 1995-Present by Columbia Magazine. Privacy policy: use of this site requires no sharing of information. Voluntarily shared information may be published and made available to the public on this site and/or stored electronically. Anonymous submissions will be subject to additional verification. Cookies are not required to use our site. However, if you have cookies enabled in your web browser, some of our advertisers may use cookies for interest-based advertising across multiple domains. For more information about third-party advertising, visit the NAI web privacy site.